Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy. [PDF]
Lima-Fontes M +7 more
europepmc +1 more source
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema. [PDF]
Morozova C +7 more
europepmc +1 more source
Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema. [PDF]
El Rayes EN, Leila M.
europepmc +1 more source
Interventions for erosive lichen planus affecting mucosal sites [PDF]
Abraham +91 more
core +1 more source
Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes [PDF]
J Coelho +4 more
openalex
Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center. [PDF]
Abu Arif J +7 more
europepmc +1 more source
The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience. [PDF]
Kozak I, Gurbaxani A, Pandova M.
europepmc +1 more source
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients. [PDF]
Sisk RA +5 more
europepmc +1 more source
Factors associated with the response to fluocinolone acetonide 0.19 mg in diabetic macular oedema evaluated as the area-under-the-curve. [PDF]
Cicinelli MV +5 more
europepmc +1 more source
Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber
Li, Angela S. +2 more
openaire +3 more sources

